Market Trends– category –
-
FDA Clears Dexcom’s Stelo Glucose Biosensor System as First OTC Continuous Glucose Monitor for Non-Insulin-Using Children Ages 2+
Weence.com USA Overview On June 12, 2026, the FDA approved Dexcom's Stelo Glucose Biosensor System as the first over-the-counter (OTC) continuous glucose monitor (CGM) for children aged 2 and older who do not use insulin. This system, wh... -
Siemens Healthineers Unveils Industry-Leading Menu for Core Lab Capillary Testing, Enhancing Diagnostic Capabilities
Science Branding Communications, Inc. Germany Overview Siemens Healthineers launched a new, industry-leading menu for core lab capillary testing on July 28, 2026. This announcement signifies a major advancement in diagnostic capabilities... -
NRCS Publishes Water & Climate Update Leveraging Soil Sensors: Eastview Farm Reports Post-Rainfall Soil Moisture Increase
Natural Resources Conservation Service USA Overview The U.S. Natural Resources Conservation Service (NRCS) released a Water & Climate Update on July 24, 2026, including data from the Eastview Farm SCAN site in Tennessee. The report d... -
Remote Monitoring Technologies Prevent Costly Disruptions in Dairy Management, Boosting Productivity and Animal Welfare
Ag Proud USA Overview Ag Proud reports that remote monitoring technologies are enhancing dairy management by automating environmental oversight and tracking equipment performance to prevent costly disruptions. These systems provide real-... -
DexCom Reports Strong Q2 2026 Results with 13% Revenue Growth, 50% Operating Income Surge
Stock Titan USA Overview DexCom announced robust Q2 2026 financial results, with revenue up 13% year-over-year, driven by increased disposable sensor volumes and an expanding customer base. The company also reported a significant 50% ris... -
Intelligent Bio Solutions Clears Cybersecurity and Software Review Items Ahead of FDA 510(k) Submission, Advancing US Market Entry
Intelligent Bio Solutions (INBS) News and Media USA Overview Intelligent Bio Solutions Inc. announced it has addressed all cybersecurity and software-related review items for its upcoming FDA 510(k) submission. This milestone, achieved a... -
MedWatch Technologies Secures $15 Million in Series A Funding for Non-Invasive Glucose Biosensor and Lifestyle Coaching Platform
Cure USA Overview MedWatch Technologies has secured $15 million in Series A financing to accelerate the development of its non-invasive biosensor for glucose-related insights and an integrated lifestyle coaching platform. This capital in... -
Biolinq’s Needle-Free Autonomous Wearable Biosensor, Shine™, Receives FDA De Novo Classification, Establishing New Device Category
EvoNexus USA Overview Biolinq, an EvoNexus graduate company, announced that its Shine™ device, a needle-free autonomous wearable biosensor, has received FDA De Novo classification. This classification creates a new regulatory category fo... -
Labman Develops Next-Gen POCT HPV Screening Device under EU ELEVATE Project: Rapid Detection of 14 HPV Strains and Two Biomarkers
News-Medical.net UK Overview Labman has developed a next-generation point-of-care (POCT) HPV screening device as part of the EU-funded ELEVATE project. This compact, portable instrument utilizes microfluidic 'lab-on-a-chip' technology to... -
Microfluidics Market Projected to Reach $37.2 Billion by 2030, Driven by POCT and Personalized Medicine
Menafn International Overview This article provides an overview of a market research report published by Menafn, forecasting the global microfluidics market to reach $37.2 billion by 2030. The growth is primarily fueled by increasing dem...
